Bridgefront Capital’s Medtronic MDT Stock Holding History

Bridgefront Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,528	Closed	-$308K	–	723
2025 Q2	$308K	Sell	3,528 -11,883	-77%	-$1.01M	0.08%	422
2025 Q1	$1.38M	Buy	15,411 +11,942	+344%	+$1.07M	0.4%	44
2024 Q4	$277K	Buy	+3,469	New	+$300K	0.09%	386
2024 Q3	–	Sell	-8,563	Closed	-$674K	–	646
2024 Q2	$674K	Buy	+8,563	New	+$702K	0.28%	107
2023 Q3	–	Sell	-2,662	Closed	-$235K	–	525
2023 Q2	$235K	Sell	2,662 -4,049	-60%	-$349K	0.13%	338
2023 Q1	$541K	Buy	+6,711	New	+$547K	0.33%	83
2022 Q3	–	Sell	-5,508	Closed	-$494K	–	405
2022 Q2	$494K	Buy	+5,508	New	+$558K	0.55%	34
2021 Q4	–	Sell	-3,922	Closed	-$492K	–	396
2021 Q3	$492K	Buy	3,922 +2,019	+106%	+$261K	0.51%	40
2021 Q2	$236K	Sell	1,903 -20,595	-92%	-$2.59M	0.09%	436
2021 Q1	$2.66M	Buy	+22,498	New	+$2.64M	0.83%	1

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridgefront Capital's MDT Position: Q3 2025 in Review

Bridgefront Capital sold out of Medtronic (MDT) in Q3 2025, closing a stake of 3,528 shares — an estimated $308K sold.

Bridgefront Capital first reported a position in MDT in Q1 2021 and held it in 10 quarters. The position peaked at $2.66M in Q1 2021. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

Bridgefront Capital reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
Bridgefront Capital sold 3,528 Medtronic shares in Q3 2025, an estimated $308K.
Bridgefront Capital first reported a position in Medtronic in Q1 2021 and held it in 10 quarters.
Bridgefront Capital's Medtronic position peaked at $2.66M in Q1 2021.
2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Bridgefront Capital's 13F filing for Q3 2025, filed 14 Nov 2025.